Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer

被引:1
|
作者
Barker, Rachel [1 ]
Biernacka, Kalina [1 ]
Kingshott, Georgina [1 ]
Sewell, Alex [2 ]
Gwiti, Paida [2 ,3 ]
Martin, Richard M. [4 ,5 ,6 ]
Lane, J. Athene [7 ]
McGeagh, Lucy [8 ]
Koupparis, Anthony [9 ]
Rowe, Edward [9 ]
Oxley, Jon [2 ]
Perks, Claire M. [1 ]
Holly, Jeff M. P. [1 ]
机构
[1] Southmead Hosp, Bristol Med Sch, IGF & Metab Endocrinol Grp, Translat Hlth Sci, Learning & Res Bldg, Bristol BS10 5NB, England
[2] Southmead Hosp, Dept Cellular Pathol, North Bristol NHS Trust, Bristol BS10 5NB, England
[3] North West Anglia NHS Fdn Trust, Dept Pathol, Peterborough PE3 2PS, England
[4] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[5] Univ Hosp Bristol, Biomed Res Ctr, Natl Inst Hlth Res, Lower Maudlin St, Bristol BS1 2LY, England
[6] Weston NHS Fdn Trust & Univ Bristol, Univ Hosp Bristol Educ Ctr, Dent Hosp, Biomed Res Unit Off, Lower Maudlin St, Bristol BS1 2LY, England
[7] Univ Bristol, Bristol Trials Ctr, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[8] Oxford Brookes Univ, Oxford Inst Nursing, Fac Hlth & Life Sci, Support Canc Care Res Grp,Midwifery & Allied Hlth, Jack Straws Lane, Oxford OX3 0FL, England
[9] Southmead Hosp, Bristol Urol Inst, Dept Urol, Bristol BS10 5NB, England
基金
英国医学研究理事会;
关键词
IGF; CTCF; FOXA1; Prostate cancer; Androgen signaling; FORKHEAD BOX A1; RECEPTOR-BINDING; RISK VARIANTS; EXPRESSION; REVEALS; BREAST; MASTER; H19;
D O I
10.1016/j.ghir.2023.101533
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To examine associations between the transcription factors CCCTC-binding factor (CTCF) and forkhead box protein A1 (FOXA1) and the androgen receptor (AR) and their association with components of the insulin-like growth factor (IGF)-pathway in a cohort of men with localized prostate cancer.Methods: Using prostate tissue samples collected during the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) trial (N = 70 to 92, depending on section availability), we assessed the abundance of CTCF, FOXA1, AR, IGFIR, p-mTOR, PTEN and IGFBP-2 proteins using a modified version of the Allred scoring system. Validation studies were performed using large, publicly available datasets (TCGA) (N = 489).Results: We identified a strong correlation between CTCF and AR staining with benign prostate tissue. CTCF also strongly associated with the IGF-IR, with PTEN and with phospho-mTOR. FOXA1 was also correlated with staining for the IGF-IR, with IGFBP-2 and with staining for activated phosphor-mTOR. The staining for the IGF-IR was strongly correlated with the AR.Conclusion: Our findings emphasise the close and complex links between the endocrine controls, well known to play an important role in prostate cancer, and the transcription factors implicated by the recent genetic evidence.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Unveiling the Molecular Landscape of FOXA1 Mutant Prostate Cancer: Insights and Prospects for Targeted Therapeutic Strategies
    Hwang, Kyung Won
    Yun, Jae Won
    Kim, Hong Sook
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (21)
  • [22] Switch in FOXA1 Status Associates with Endometrial Cancer Progression
    Tangen, Ingvild Loberg
    Krakstad, Camilla
    Halle, Mari K.
    Werner, Henrica M. J.
    Oyan, Anne M.
    Kusonmano, Kanthida
    Petersen, Kjell
    Kalland, Karl Henning
    Akslen, Lars A.
    Trovik, Jone
    Hurtado, Antoni
    Salvesen, Helga B.
    PLOS ONE, 2014, 9 (05):
  • [23] FOXA1 Modulates EAF2 Regulation of AR Transcriptional Activity, Cell Proliferation, and Migration in Prostate Cancer Cells
    Guo, Wenhuan
    Keener, Anne L.
    Jing, Yifeng
    Cai, Liquan
    Ai, Junkui
    Zhang, Jian
    Fu, Guohui
    Wang, Zhou
    PROSTATE, 2015, 75 (09) : 976 - 987
  • [24] LSD1 inhibitor hinders the demethylation of FOXA1 to inhibit prostate cancer progression
    Zhu, Yongzhen
    Ma, Lijia
    Zhang, Wen
    Wu, Xuelian
    MATERIALS EXPRESS, 2023, 13 (12) : 1990 - 1995
  • [25] Role of transcription factor FOXA1 in non-small cell lung cancer
    Li, Jia
    Zhang, Shirong
    Zhu, Lucheng
    Ma, Shenglin
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 509 - 521
  • [26] FOXA1: master of steroid receptor function in cancer
    Augello, Michael A.
    Hickey, Theresa E.
    Knudsen, Karen E.
    EMBO JOURNAL, 2011, 30 (19) : 3885 - 3894
  • [27] FOXA1: a Promising Prognostic Marker in Breast Cancer
    Hu, Qing
    Luo, Zhou
    Xu, Tao
    Zhang, Jun-Ying
    Zhu, Ying
    Chen, Wei-Xian
    Zhong, Shan-Liang
    Zhao, Jian-Hua
    Tang, Jin-Hai
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 11 - 16
  • [28] Independence of HIF1a and androgen signaling pathways in prostate cancer
    Maxine G. B. Tran
    Becky A. S. Bibby
    Lingjian Yang
    Franklin Lo
    Anne Y. Warren
    Deepa Shukla
    Michelle Osborne
    James Hadfield
    Thomas Carroll
    Rory Stark
    Helen Scott
    Antonio Ramos-Montoya
    Charlie Massie
    Patrick Maxwell
    Catharine M. L. West
    Ian G. Mills
    David E. Neal
    BMC Cancer, 20
  • [29] A role for androgen receptor variant 7 in sensitivity to therapy: Involvement of IGFBP-2 and FOXA1
    Biernacka, K. M.
    Barker, R.
    Sewell, A.
    Bahl, A.
    Perks, C. M.
    TRANSLATIONAL ONCOLOGY, 2023, 34
  • [30] FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression
    Yiming Su
    Yu Zhang
    Jing Zhao
    Wenhao Zhou
    Wenhao Wang
    Bangmin Han
    Xiaohai Wang
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3225 - 3243